If not now, when? seizing the moment for antibiotic stewardship

Infection Control and Hospital Epidemiology

Volumn 34, Issue 2, 2013, Pages 117-118

  Pollack, Lori A ^a   Gould, Carolyn V ^a   Srinivasan, Arjun ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; HUMAN; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL RECORD REVIEW; POINT OF CARE TESTING;

ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; UNNECESSARY PROCEDURES;

EID: 84872187516     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/669228     Document Type: Article

References (11)

1. Hermsen ED, VanSchooneveld TC, Sayles H, Rupp ME. Implementation of a clinical decision support system for antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33(4): 412-415.
2. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003;36: 440-446.
3. Sax H, Allegranzi B, Uckay I, Larson E, Boyce J, Pittet D. "My five moments for hand hygiene": a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 2007;67(1):9-21.
4. Shaughnessy MK, Amundsen WH, Kuskowski MA, DeCarolis DD, Johnson JR, Drekonja DM. Unnecessary antimicroibial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2013;34(2):109-116.
5. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
6. Johnson S. Meeting the challenge of recurrent Clostridium difficile infection. J Hosp Med 2012;7(suppl 3):S11-S13.
7. Drekonja DM, Amundson WH, DeCarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 2011;124(11):1081.e1-1081.e7.
8. Cope M, Cevallos ME, Cadle RM, Darouiche RO, Musher DM, Trautner BW. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 2009;48:1182-1188.
9. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in communityacquired pneumonia. Am J Med 2006;119(10):865-871.
10. Aldeyab MA, Kearney MP, Scott MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of highrisk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012;67(12):2988-2996.
11. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53(1):42-48.